logo
logo
Sign in

The global Automated CPR Devices Market Growth Accelerated by Increased Adoption in Hospitals

avatar
Niranjan Mardakar
The global Automated CPR Devices Market Growth Accelerated by Increased Adoption in Hospitals

Automated chest compression devices provide consistent, high-quality CPR to patients in cardiac arrest. These devices ensure compressions are performed at the correct depth and rate, addressing one of the biggest obstacles in delivering effective manual CPR. With many hospitals and emergency medical systems increasingly adopting these devices.

The global Automated CPR Devices Market is estimated to be valued at US$ 127.6 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends driving growth in the automated CPR devices market is the increased adoption in hospitals. Modern CPR devices are portable, battery-powered devices that can be used in ambulances, emergency rooms, operating rooms and intensive care units to provide effective chest compressions. Many hospitals are recognizing the benefits of these devices in resuscitating patients and are therefore investing in automated CPR devices. With growing awareness about the importance of high-quality CPR and evidence that automated devices improve resuscitation outcomes, adoption in hospitals is expected to significantly rise over the forecast period, propelling the overall market growth.


Segment Analysis

The Global Automated CPR Devices Market Size is dominated by piston-based devices. These devices implement piston-based compression mechanism to provide uninterrupted chest compressions at a consistent rate and depth to patients requiring CPR. They ensure higher accuracy and eliminate human errors associated with manual CPR, thus making them preferred among healthcare professionals. The electric pump-based automated CPR devices segment is also growing owing to advantages such as portability and battery back-up.

Key Takeaways

The global automated CPR devices market is expected to witness high growth over the forecast period of 2023 to 2030. The market is projected to reach a value of US$ 212.9 Mn by 2030, expanding at a CAGR of 6.8% during the forecast period.

Regional analysis

North America dominated the global automated CPR devices market in 2023 and is expected to continue its dominance throughout the forecast period. High healthcare spending and presence of major players in the region are contributing to its large share. Asia Pacific is anticipated to be the fastest growing regional market between 2023 and 2030 due to rising incidence of cardiac arrests, improving healthcare infrastructure, and increasing adoption of automated CPR devices.

Key players

Key players operating in the automated CPR devices market are GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Novartis AG, AstraZeneca PLC, Sanofi S.A., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Perrigo Company plc, NeilMed Pharmaceuticals, Inc., Church & Dwight Co., Inc., Navage, Inc., Xlear, Inc.

Get More Insights On This Topic: https://www.newsstatix.com/automated-cpr-devices-market-size-share-analysis-2023-2030/

collect
0
avatar
Niranjan Mardakar
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more